A Technical Guide for Passive Scattering Proton Radiation Therapy for Breast Cancer

Overview

Journal Int J Part Ther

Publisher Elsevier

Specialty Radiology

Date 2019 Nov 28

PMID 31772997

Citations 8

Authors

Julie A Bradley

Meng Wei Ho

Zuofeng Li

Xiaoying Liang

Michael Rutenberg

Roi Dagan

Nancy P Mendenhall

Affiliations

Soon will be listed here.

Abstract

Most patients treated with proton therapy have had eye tumors, sarcomas, or, more recently, pediatric, or prostate cancers. As more proton centers have developed globally, increased capacity will permit exploration of other potential indications for proton therapy, including for the treatment of breast cancer. The rationale for proton therapy in the treatment of breast cancer is reduced inadvertent radiation dose to the heart and lung, as well as improved target coverage. As with any new technology, multiple technical parameters require optimization to deliver safe and effective radiation therapy and to maximize the benefits of the new technology. The purpose of this report is to provide a technical guide for the treatment of breast cancer with passive-scattering proton therapy and an algorithm for selecting patients with breast cancer who would benefit from proton therapy.

Citing Articles

Narrative Review: Cardiotoxicities and Cardiac-Sparing Techniques in Radiotherapy.

Chan M, Parikh D, Shi C Technol Cancer Res Treat. 2024; 23:15330338241301211.

PMID: 39636079 PMC: 11622324. DOI: 10.1177/15330338241301211.

Dosimetric Correlation of Acute Radiation Dermatitis in Patients With Breast Cancer Undergoing Hypofractionated Proton Beam Therapy Using Pencil Beam Scanning.

Huang E, Wei Ho M, Wang Y J Breast Cancer. 2024; 27(3):187-200.

PMID: 38769685 PMC: 11221205. DOI: 10.4048/jbc.2024.0012.

Incidence of Rib Fracture following Treatment with Proton Therapy for Breast Cancer.

Bradley J, Liang X, Vega R, Liu C, Brooks E, Burchianti T Int J Part Ther. 2023; 9(4):269-278.

PMID: 37169006 PMC: 10166011. DOI: 10.14338/IJPT-22-00034.1.

Hyperfractionated-Accelerated Reirradiation with Proton Therapy for Radiation-Associated Breast Angiosarcoma.

Looi W, Bradley J, Liang X, Shaw C, Leyngold M, Vega R Int J Part Ther. 2022; 8(4):55-67.

PMID: 35530187 PMC: 9009453. DOI: 10.14338/IJPT-21-00031.1.

Proton Beam Therapy for Head and Neck Carcinoma of Unknown Primary: Toxicity and Quality of Life.

Sherry A, Pasalic D, Gunn G, Fuller C, Phan J, Rosenthal D Int J Part Ther. 2021; 8(1):234-247.

PMID: 34285950 PMC: 8270080. DOI: 10.14338/IJPT-20-00034.1.

References

Darby S, McGale P, Taylor C, Peto R . Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol. 2005; 6(8):557-65. DOI: 10.1016/S1470-2045(05)70251-5. View

Dincoglan F, Beyzadeoglu M, Sager O, Oysul K, Kahya Y, Gamsiz H . Dosimetric evaluation of critical organs at risk in mastectomized left-sided breast cancer radiotherapy using breath-hold technique. Tumori. 2013; 99(1):76-82. DOI: 10.1177/030089161309900113. View

Brown L, Diehn F, Boughey J, Childs S, Park S, Yan E . Delineation of Supraclavicular Target Volumes in Breast Cancer Radiation Therapy. Int J Radiat Oncol Biol Phys. 2015; 92(3):642-9. DOI: 10.1016/j.ijrobp.2015.02.022. View

Chang J, Lee N, Kim J, Kim Y, Moon S, Kim T . Phase II trial of proton beam accelerated partial breast irradiation in breast cancer. Radiother Oncol. 2013; 108(2):209-14. DOI: 10.1016/j.radonc.2013.06.008. View

Bradley J, Dagan R, Wei Ho M, Rutenberg M, Morris C, Li Z . Initial Report of a Prospective Dosimetric and Clinical Feasibility Trial Demonstrates the Potential of Protons to Increase the Therapeutic Ratio in Breast Cancer Compared With Photons. Int J Radiat Oncol Biol Phys. 2015; 95(1):411-421. DOI: 10.1016/j.ijrobp.2015.09.018. View

Taylor C, Kirby A . Cardiac Side-effects From Breast Cancer Radiotherapy. Clin Oncol (R Coll Radiol). 2015; 27(11):621-9. DOI: 10.1016/j.clon.2015.06.007. View

Thorsen L, Offersen B, Dano H, Berg M, Jensen I, Pedersen A . DBCG-IMN: A Population-Based Cohort Study on the Effect of Internal Mammary Node Irradiation in Early Node-Positive Breast Cancer. J Clin Oncol. 2015; 34(4):314-20. DOI: 10.1200/JCO.2015.63.6456. View

Veiga C, Janssens G, Teng C, Baudier T, Hotoiu L, McClelland J . First Clinical Investigation of Cone Beam Computed Tomography and Deformable Registration for Adaptive Proton Therapy for Lung Cancer. Int J Radiat Oncol Biol Phys. 2016; 95(1):549-559. DOI: 10.1016/j.ijrobp.2016.01.055. View

MacDonald S, Patel S, Hickey S, Specht M, Isakoff S, Gadd M . Proton therapy for breast cancer after mastectomy: early outcomes of a prospective clinical trial. Int J Radiat Oncol Biol Phys. 2013; 86(3):484-90. DOI: 10.1016/j.ijrobp.2013.01.038. View

10.

Overgaard M, Jensen M, Overgaard J, Hansen P, Rose C, Andersson M . Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet. 1999; 353(9165):1641-8. DOI: 10.1016/S0140-6736(98)09201-0. View

11.

Nielsen M, Berg M, Pedersen A, Andersen K, Glavicic V, Jakobsen E . Delineation of target volumes and organs at risk in adjuvant radiotherapy of early breast cancer: national guidelines and contouring atlas by the Danish Breast Cancer Cooperative Group. Acta Oncol. 2013; 52(4):703-10. DOI: 10.3109/0284186X.2013.765064. View

12.

Mast M, Vredeveld E, Credoe H, van Egmond J, Heijenbrok M, Hug E . Whole breast proton irradiation for maximal reduction of heart dose in breast cancer patients. Breast Cancer Res Treat. 2014; 148(1):33-9. PMC: 4196139. DOI: 10.1007/s10549-014-3149-6. View

13.

Chang J, Park W, Kim Y, Lee I, Keum K, Lee C . Long-term survival outcomes following internal mammary node irradiation in stage II-III breast cancer: results of a large retrospective study with 12-year follow-up. Int J Radiat Oncol Biol Phys. 2013; 86(5):867-72. DOI: 10.1016/j.ijrobp.2013.02.037. View

14.

Verhoeven K, Weltens C, Remouchamps V, Mahjoubi K, Veldeman L, Lengele B . Vessel based delineation guidelines for the elective lymph node regions in breast cancer radiation therapy - PROCAB guidelines. Radiother Oncol. 2014; 114(1):11-6. DOI: 10.1016/j.radonc.2014.11.008. View

15.

Batin E, Depauw N, MacDonald S, Lu H . Can surface imaging improve the patient setup for proton postmastectomy chest wall irradiation?. Pract Radiat Oncol. 2016; 6(6):e235-e241. DOI: 10.1016/j.prro.2016.02.001. View

16.

Moyers M, Miller D, Bush D, Slater J . Methodologies and tools for proton beam design for lung tumors. Int J Radiat Oncol Biol Phys. 2001; 49(5):1429-38. DOI: 10.1016/s0360-3016(00)01555-8. View

17.

Cuaron J, Chon B, Tsai H, Goenka A, DeBlois D, Ho A . Early toxicity in patients treated with postoperative proton therapy for locally advanced breast cancer. Int J Radiat Oncol Biol Phys. 2015; 92(2):284-91. PMC: 4972493. DOI: 10.1016/j.ijrobp.2015.01.005. View

18.

Ragaz J, Olivotto I, Spinelli J, Phillips N, Jackson S, Wilson K . Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst. 2005; 97(2):116-26. DOI: 10.1093/jnci/djh297. View

19.

Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans V . Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005; 366(9503):2087-106. DOI: 10.1016/S0140-6736(05)67887-7. View

20.

Wang P, Yin L, Zhang Y, Kirk M, Song G, Ahn P . Quantitative assessment of anatomical change using a virtual proton depth radiograph for adaptive head and neck proton therapy. J Appl Clin Med Phys. 2016; 17(2):427-440. PMC: 5875558. DOI: 10.1120/jacmp.v17i2.5819. View